Journal of Jilin University Medicine Edition ›› 2016, Vol. 42 ›› Issue (06): 1138-1142.doi: 10.13481/j.1671-587x.20160617

Previous Articles     Next Articles

Expressions of hMOFprotein and mRNA in endometrial cancer tissue and their clinical significances

WEN Aiping1, WANG Haijiao2, JIN Jingji3, CAI Yong3, ZHU Jihong4, CHEN Lunhua1   

  1. 1. Departement of Obstetrics and Gynecology, Affiliated Hospital, North Sichuan Medical College, Nanchong 637000, China;
    2. Department of Obstetrics and Gynecology, First Hospital, Jilin University, Changchun 130021, China;
    3. National Key Laboratory of Acquired Immune Deficiency Syndrome, Department of Epigenetics, School of Life Sciences, Jilin University, Changchun 130012, China;
    4. Reproductive Medicine Center, First Hospital, Jilin University, Changchun 30021, China
  • Received:2016-01-30 Online:2016-11-28 Published:2016-12-02

Abstract:

Objective: To discuss the expressions of hMOF protein and mRMA in endometrial cancer tissue,and to illuminate the possible mechanism of hMOF in the occurrence and development of endometrial cancer.Methods: The PT-PCR and immunohistochemistry methods were used to detect the expressions of hMOF protein and mRNA in 38 cases of endomerial cancer tissues and 20 cases of normal endometrial tissues,and to analyze the relationship between its expression level and the clinical characteristics and prognosis of the patients with endometrial cancer.Results: The immunohistochemistry results showed that the positive expression rate of hMOF protein in endometrial cancer tissue was lower than those in normal endometrial tissue(P=0.037); the positive expression rate of hMOF protein in stage Ⅰ patients was higher than those in stage Ⅱ and Ⅲ-Ⅳ patients(χ2=6.591,P=0.037);the positive exprssion rate of hMOF protein in the patients with poor differentiation was lower than those in the patients with moderate and high differentiation(χ2=7.351,P=0.025).The RT-PCR results showed that the percentage of the patients with expression up-regulation of hMOF mRNA in endometrial carcinoma tissue was remarkly decreased compared with normal endometrial tissue(P=0.003).Conclusion: hMOF protein may participate in the occurrence and development of endometrial cancer,and hMOF protein could be a biomarker for prognosis of endometrial cancer.

Key words: endometrial neoplasms, polymerase chain reaction, immunohistochemistry, acetyltransferases, adenocarcinoma

CLC Number: 

  • R737.33